» DRUG DELIVERY
»
References 1.
2. 3. 4. 5. 6. 7. 8. 9. 10. 11.
V.P. Torchilin. Drug targeting. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 11 Suppl 2:S81-91 (2000).
D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer. Nanocarriers as an emerging platform for cancer therapy. Nature nanotechnology. 2:751-760 (2007).
A. Grana, A. Limpach, and H. Chauhan. Formulation considerations and applications of solid lipid nanoparticles. American Pharmaceutical Review. 16: (2013).
A.S. Williams, J.P. Camilleri, R.M. Goodfellow, and B.D. Williams. A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. British journal of rheumatology. 35:719-724 (1996).
L. Marchal-Heussler, D. Sirbat, M. Hoffman, and P. Maincent. Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery. Pharmaceutical research. 10:386-390 (1993).
F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, and R.K. Jain. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer research. 55:3752-3756 (1995).
A.A. Gabizon. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer research. 52:891- 896 (1992).
S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji. A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of controlled release : official journal of the Controlled Release Society. 126:187-204 (2008).
L.E. Gerweckand K. Seetharaman. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer research. 56:1194-1198 (1996).
P. Vaupel, F. Kallinowski, and P. Okunieff. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer research. 49:6449- 6465 (1989).
J.L. Wike-Hooley, J. Haveman, and H.S. Reinhold. The relevance of tumour pH to the treatment of malignant disease. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2:343-366 (1984).
12. H. Kamada, Y. Tsutsumi, Y. Yoshioka, Y. Yamamoto, H. Kodaira, S. Tsunoda, T. Okamoto, Y. Mukai, H. Shibata, S. Nakagawa, and T. Mayumi. Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 10:2545-2550 (2004).
13. H. Devalapally, D. Shenoy, S. Little, R. Langer, and M. Amiji. Poly(ethylene oxide)- modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor- targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Cancer chemotherapy and pharmacology. 59:477- 484 (2007).
14. D. Shenoy, S. Little, R. Langer, and M. Amiji. Poly(ethylene oxide)-modified poly(beta- amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Molecular pharmaceutics. 2:357-366 (2005).
15. 16.
V.P. Torchilin. Multifunctional nanocarriers. Advanced drug delivery reviews. 58:1532- 1555 (2006).
E. Roux, C. Passirani, S. Scheffold, J.P. Benoit, and J.C. Leroux. Serum-stable and long- circulating, PEGylated, pH-sensitive liposomes. Journal of controlled release : official journal of the Controlled Release Society. 94:447-451 (2004).
17. D.E. Meyer, B.C. Shin, G.A. Kong, M.W. Dewhirst, and A. Chilkoti. Drug targeting using thermally responsive polymers and local hyperthermia. Journal of controlled release : official journal of the Controlled Release Society. 74:213-224 (2001).
70 | | September/October 2013 - 15TH ANNIVERSARY ISSUE 28. 29.
18. A.M. Ponce, Z. Vujaskovic, F. Yuan, D. Needham, and M.W. Dewhirst. Hyperthermia mediated liposomal drug delivery. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 22:205-213 (2006).
19. D. Schmaljohann. Thermo- and pH-responsive polymers in drug delivery. Advanced drug delivery reviews. 58:1655-1670 (2006).
20. M. Nakayama, T. Okano, T. Miyazaki, F. Kohori, K. Sakai, and M. Yokoyama. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. Journal of controlled release : official journal of the Controlled Release Society. 115:46- 56 (2006).
21. 22.
K. Kono, K. Yoshino, and T. Takagishi. Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes. Journal of controlled release : official journal of the Controlled Release Society. 80:321-332 (2002).
H.D. Han, B.C. Shin, and H.S. Choi. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 62:110-116 (2006).
23.
V. Torchilin. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 71:431-444 (2009).
24. G. Cavallaro, M. Campisi, M. Licciardi, M. Ogris, and G. Giammona. Reversibly stable thiopolyplexes for intracellular delivery of genes. Journal of controlled release : official journal of the Controlled Release Society. 115:322-334 (2006).
25. D. Kirpotin, K. Hong, N. Mullah, D. Papahadjopoulos, and S. Zalipsky. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS letters. 388:115-118 (1996).
26. 27.
K.J. Widder, A.E. Senyel, and G.D. Scarpelli. Magnetic microspheres: a model system of site specific drug delivery in vivo. Proc Soc Exp Biol Med. 158:141-146 (1978).
J. Gang, S.B. Park, W. Hyung, E.H. Choi, J. Wen, H.S. Kim, Y.G. Shul, S. Haam, and S.Y. Song. Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model. Journal of drug targeting. 15:445-453 (2007).
G.A. Husseini, M.A. Diaz de la Rosa, T. Gabuji, Y. Zeng, D.A. Christensen, and W.G. Pitt. Release of doxorubicin from unstabilized and stabilized micelles under the action of ultrasound. Journal of nanoscience and nanotechnology. 7:1028-1033 (2007).
S.D. Tiukinhoy-Laing, K. Buchanan, D. Parikh, S. Huang, R.C. MacDonald, D.D. McPherson, and M.E. Klegerman. Fibrin targeting of tissue plasminogen activator- loaded echogenic liposomes. Journal of drug targeting. 15:109-114 (2007).
30. A. Beduneau, P. Saulnier, and J.P. Benoit. Active targeting of brain tumors using nanocarriers. Biomaterials. 28:4947-4967 (2007).
31. 32.
E.S. Vitetta, K.A. Krolick, M. Miyama-Inaba, W. Cushley, and J.W. Uhr. Immunotoxins: a new approach to cancer therapy. Science. 219:644-650 (1983).
V.P. Torchilin. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. The AAPS journal. 9:E128-147 (2007).
33. H.M. Warenius, G. Galfre, N.M. Bleehen, and C. Milstein. Attempted targeting of a monoclonal antibody in a human tumour xenograft system. European journal of cancer & clinical oncology. 17:1009-1015 (1981).
34. 35.
J. Albanelland J. Baselga. Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer. Drugs Today (Barc). 35:931-946 (1999).
S. Ni, S.M. Stephenson, and R.J. Lee. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer research. 22:2131-2135 (2002).
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156